These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9748133)

  • 1. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
    Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
    Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.
    Porrini R; Vercellino V; Rocchetti V; Renò F; Giorda E; Pomato E; Cannas M; Sabbatini M
    Minerva Stomatol; 2010 May; 59(5):233-9, 239-43. PubMed ID: 20502428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
    Castelli M; Cianfriglia F; Manieri A; Palma L; Pezzuto RW; Falasca G; Delpino A
    Anticancer Res; 2001; 21(1B):753-8. PubMed ID: 11299839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
    Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
    Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum p53 antibodies in patients with oral lesions: correlation with p53/HSP70 complexes.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1997 Dec; 74(6):609-13. PubMed ID: 9421357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.
    Trivers GE; De Benedetti VM; Cawley HL; Caron G; Harrington AM; Bennett WP; Jett JR; Colby TV; Tazelaar H; Pairolero P; Miller RD; Harris CC
    Clin Cancer Res; 1996 Oct; 2(10):1767-75. PubMed ID: 9816128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
    Bathi RJ; Prabhat
    Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of antibodies against p53 in patients with oral squamous cell carcinoma--five years survival rate].
    Hofele C; Schwager-Schmitt M; Volkmann M
    Laryngorhinootologie; 2002 May; 81(5):342-5. PubMed ID: 12001023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
    Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
    Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
    Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients.
    Warnakulasuriya S; Soussi T; Maher R; Johnson N; Tavassoli M
    J Pathol; 2000 Sep; 192(1):52-7. PubMed ID: 10951400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters.
    Gao RJ; Bao HZ; Yang Q; Cong Q; Song JN; Wang L
    Breast Cancer Res Treat; 2005 Sep; 93(2):111-5. PubMed ID: 16187230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
    Shimada H; Ochiai T; Nomura F;
    Cancer; 2003 Feb; 97(3):682-9. PubMed ID: 12548611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.